9,426 Shares in Oppenheimer Holdings Inc. (NYSE:OPY) Purchased by Walleye Capital LLC

Walleye Capital LLC acquired a new stake in Oppenheimer Holdings Inc. (NYSE:OPY - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 9,426 shares of the financial services provider's stock, valued at approximately $604,000. Walleye Capital LLC owned 0.09% of Oppenheimer as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Empowered Funds LLC boosted its stake in shares of Oppenheimer by 4.9% in the fourth quarter. Empowered Funds LLC now owns 34,511 shares of the financial services provider's stock valued at $2,212,000 after buying an additional 1,620 shares during the period. JPMorgan Chase & Co. raised its holdings in Oppenheimer by 10.4% in the 4th quarter. JPMorgan Chase & Co. now owns 18,940 shares of the financial services provider's stock valued at $1,214,000 after acquiring an additional 1,787 shares in the last quarter. Profit Investment Management LLC lifted its position in shares of Oppenheimer by 5.2% during the 4th quarter. Profit Investment Management LLC now owns 49,394 shares of the financial services provider's stock valued at $3,166,000 after acquiring an additional 2,445 shares during the period. TCW Group Inc. increased its position in shares of Oppenheimer by 3.5% in the fourth quarter. TCW Group Inc. now owns 79,300 shares of the financial services provider's stock worth $5,082,000 after purchasing an additional 2,700 shares during the period. Finally, Arrowstreet Capital Limited Partnership increased its position in shares of Oppenheimer by 3.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 90,566 shares of the financial services provider's stock worth $5,804,000 after purchasing an additional 3,119 shares during the period. Institutional investors and hedge funds own 32.26% of the company's stock.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Oppenheimer from a "strong-buy" rating to a "buy" rating in a research report on Monday, February 3rd.

Oppenheimer Stock Performance

NYSE OPY opened at $56.66 on Wednesday. The firm's 50 day simple moving average is $59.72 and its 200 day simple moving average is $60.90. The firm has a market capitalization of $596.35 million, a price-to-earnings ratio of 8.89 and a beta of 1.10. The company has a current ratio of 1.29, a quick ratio of 0.80 and a debt-to-equity ratio of 0.13. Oppenheimer Holdings Inc. has a 1 year low of $38.09 and a 1 year high of $73.12.

Oppenheimer (NYSE:OPY - Get Free Report) last issued its earnings results on Friday, January 31st. The financial services provider reported $0.92 earnings per share for the quarter. Oppenheimer had a return on equity of 8.76% and a net margin of 5.00%.

Oppenheimer Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were issued a $0.18 dividend. The ex-dividend date was Friday, February 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.27%. Oppenheimer's dividend payout ratio (DPR) is currently 11.30%.

Oppenheimer Company Profile

Oppenheimer Holdings Inc operates as a middle-market investment bank and full-service broker-dealer in the Americas, Europe, the Middle East, and Asia. The company provides brokerage services covering corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; financial and wealth planning services; and margin lending services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.